Literature DB >> 606555

The effect of nacom (L-dopa and L-carbidopa) on growth hormone secretion in 75 patients with short stature.

W Schönberger, W Grimm, R Ziegler.   

Abstract

The stimulatory effect of Nacom (250 mg L-Dopa and 25 mg L-Carbidopa) on the HGH secretion was evaluated in 75 short stature patients. The number of blood samples was restricted to only three (0, 45 and 90 min). 63 patients reached adequate HGH concentrations after the ingestion of 1 tablet Nacom (84%). Somatotropin levels increased from 2.08 (Sx 0.28) to a maximal HGH value of 14.22 (Sx 0.87) ng/ml. When the stimulatory effect of Nacom was compared with the standard method of arginine infusion in children with normal stature the arginine test was not superior to the Nacom-test. The Nacom-test appears to be a simple and reliable screening method for HGH deficiency, particularly in outpatients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 606555     DOI: 10.1007/bf00465561

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Stimulatory effect of exogenous catecholamines on plasma HGH concentrations in presence of beta adrenergic blockade.

Authors:  W G Blackard; G J Hubbell
Journal:  Metabolism       Date:  1970-07       Impact factor: 8.694

2.  Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion.

Authors:  F Massara; F Camanni
Journal:  J Endocrinol       Date:  1972-08       Impact factor: 4.286

3.  The use of L-DOPA in the diagnosis of hyposomatotropism in children.

Authors:  V V Weldon; S K Gupta; M W Haymond; A S Pagliara; L S Jacobs; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

4.  Apparent inadequency of L-dopa stimulation as a clinical test of growth hormone release.

Authors:  C Gómez-Sánchez; N M Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

5.  Exercise as a screening test for growth hormone release.

Authors:  J M Buckler
Journal:  Acta Endocrinol (Copenh)       Date:  1972-02

6.  Stimulation of human-growth-hormone secretion by L-dopa.

Authors:  A E Boyd; H E Lebovitz; J B Pfeiffer
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

7.  Effects of autonomic blocking agents on growth hormone, insulin, free fatty acids and glucose in baboons.

Authors:  J H Werrbach; C C Gale; C J Goodner; M J Conway
Journal:  Endocrinology       Date:  1970-01       Impact factor: 4.736

8.  [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].

Authors:  W Schönberger; R Ziegler; B Brodt; W Grimm
Journal:  Eur J Pediatr       Date:  1976-06-08       Impact factor: 3.183

9.  Adrenergic receptor control mechanism for growth hormone secretion.

Authors:  W G Blackard; S A Heidingsfelder
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

10.  Human growth hormone secretion after exercise and oral glucose administration in patients with short stature.

Authors:  Y Okada; T Hikata; K Ishitobi; M Wada; Y Santo; Y Harada
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

View more
  2 in total

Review 1.  Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; V Locatelli; E Ghigo; S G Cella; S Loche; C Pintor; F Camanni
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

2.  Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.

Authors:  A Martinez-Campos; P Giovannini; E Parati; A Novelli; T Caraceni; E E Müller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.